Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A3384 in bile acid malabsorption/bile acid diarrhoea
2013-002924-17Phase 2Terminated
- Sponsor
- Albireo Pharma
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of A3384 in bile acid diarrhea (BAD) and Bile acid diarrhea (BAD) (3 arms), sponsored by Albireo Pharma. Primary endpoint: Change from baseline in number of bowel movements during the second treatment week. Started Nov 2013; status: terminated.
02
Drugs
A3384
03
Conditions
bile acid diarrhea (BAD)Bile acid diarrhea (BAD)
Beyond the preview
Go deeper on 2013-002924-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002924-17.